Start free

Orchestra BioMed Holdings, Inc. (OBIO) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 20, 2026.

Filings shown
36
Open-market buys
12
Open-market sells
6
Buys, 10b5-1 box not checked
12 of 12

Counts cover the 36 most recent Form 4 filings Tradune holds for OBIO (filed May 18 – Nov 20, 2026); the score below covers only the trailing 90 days (7 buys, 3 sells). SEC EDGAR Form 4 filings for OBIO last checked Nov 21, 2026, 09:00 UTC; the latest OBIO filing Tradune holds was filed Nov 20, 2026. This is not guaranteed to be the complete record — see OBIO's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 14 filings Tradune holds for OBIO filed Aug 28 – Nov 20, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

3 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
3 sales· 45,000 sh
checkbox disclosed
On filings with the box not checked
0 sales· 0 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Darren ShermanOfficer (see filing) 1 3 2,000 45,000 +$10,660 / −$255,600
David P. HochmanOfficer (see filing) 2 0 15,000 — +$72,900
RTW Investments, LP10% owner 1 0 1,200,000 — +$6,000,000
Eric S. FainDirector 1 0 20,000 — +$100,000
David PacittiDirector 1 0 20,000 — +$100,000
Andrew Lawrence TaylorChief Financial Officer 1 0 1,000 — +$5,000

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

100/ 100

Purchase cluster incl. officer
6 distinct buyers7 buy · 3 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

Weekly signal history

OBIO appeared in 2 archived weekly editions as a multi-insider cluster, a top net buyer, or both. These are frozen weekly snapshots, not a complete filing history.

  1. Week of Nov 17, 2026
    6 insiders buying · $6,032,960 net
  2. Week of Nov 10, 2026
    4 insiders buying · $143,900 net

An entry means this company met that edition’s displayed cluster or top-buyer threshold. Missing weeks do not mean no insider transaction occurred. All figures are derived from SEC Form 4 filings; open-market buys minus sales are shown as net only when every transaction value was disclosed.

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at OBIO

Insiders reported 12 open-market purchases of OBIO between May 18, 2026 and Nov 20, 2026, across 7 distinct buyers. The most recent purchase was reported by Andrew Lawrence Taylor (Chief Financial Officer) on Nov 9, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Andrew Lawrence Taylor Chief Financial Officer · filed Nov 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 3,076 $6.58 587,913 −0.5% Nov 20, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

RTW Investments, LP 10% owner · filed Nov 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,200,000 $5.00 10,756,063 (indirect) +13% Nov 9, 2026

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Eric S. Fain Director · filed Nov 9, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 20,000 $5.00 119,630 (indirect) +20% Nov 9, 2026
David Pacitti Director · filed Nov 9, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 20,000 $5.00 74,750 +37% Nov 9, 2026
David P. Hochman Officer (see filing) · filed Nov 9, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 5,000 $5.00 437,916 (indirect) +1.2% Nov 9, 2026
Andrew Lawrence Taylor Chief Financial Officer · filed Nov 9, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 1,000 $5.00 590,989 +0.2% Nov 9, 2026
Darren Sherman Officer (see filing) · filed Nov 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 15,000 $5.74 1,104,402 −1.3% Nov 2, 2026
Darren Sherman Officer (see filing) · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 15,000 $6.36 1,119,402 −1.3% Oct 1, 2026
David P. Hochman Officer (see filing) · filed Sep 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 3,283 $5.81 1,067,463 −0.3% Sep 10, 2026
Tax withholding 3,283 $5.81 432,916 (indirect) −0.8% Sep 10, 2026
David P. Hochman Officer (see filing) · filed Sep 8, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 10,000 $4.79 1,070,746 +0.9% Sep 3, 2026
Darren Sherman Officer (see filing) · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 15,000 $4.94 1,134,402 −1.3% Sep 1, 2026
Andrew Lawrence Taylor Chief Financial Officer · filed Aug 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 3,076 $5.26 589,989 −0.5% Aug 26, 2026
Darren Sherman Officer (see filing) · filed Aug 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,925 $5.26 1,149,402 −0.4% Aug 26, 2026
Open-market purchase 10b5-1 box not checked 2,000 $5.33 2,000 (indirect) — Aug 26, 2026
Joshua Aiello Principal Accounting Officer · filed Aug 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 203 $5.26 18,441 −1.1% Aug 26, 2026
David Pacitti Director · filed Aug 14, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 3,761 $4.42 54,750 −6.4% Aug 12, 2026
Eric S. Fain Director · filed Aug 14, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 5,145 $4.42 99,630 (indirect) −4.9% Aug 12, 2026
John Prosper Mack Director · filed Aug 14, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,885 $4.42 66,544 −6.8% Aug 12, 2026
Chris Cleary Director · filed Aug 14, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,238 $4.42 29,153 −13% Aug 12, 2026
Darren Sherman Officer (see filing) · filed Aug 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 15,000 $4.09 1,154,327 −1.3% Aug 3, 2026
Darren Sherman Officer (see filing) · filed Jul 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 15,000 $4.27 1,169,327 −1.3% Jul 1, 2026
Eric S. Fain Director · filed Jun 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,261 — 104,775 (indirect) −3.9% Jun 24, 2026
Grant / award 17,327 — 109,036 (indirect) +19% Jun 23, 2026
Grant / award Stock Option (Right to Buy) 21,277 — — — Jun 23, 2026
David Pacitti Director · filed Jun 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 3,784 — 58,511 −6.1% Jun 24, 2026
Grant / award 17,327 — 62,295 +39% Jun 23, 2026
Grant / award Stock Option (Right to Buy) 21,277 — — — Jun 23, 2026
Chris Cleary Director · filed Jun 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 3,510 — 33,391 −9.5% Jun 24, 2026
Grant / award Stock Option (Right to Buy) 42,553 — — — Jun 23, 2026
John Prosper Mack Director · filed Jun 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 3,510 — 71,429 −4.7% Jun 24, 2026
Grant / award 34,653 — 74,939 +86% Jun 23, 2026
Pamela Ann Connealy Director · filed Jun 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 17,327 — 66,038 +36% Jun 23, 2026
Grant / award Stock Option (Right to Buy) 21,277 — — — Jun 23, 2026

Listing the 25 most recent of 36 Form 4 filings held for OBIO; the 11 older filings (filed May 18 – Jun 25, 2026) are counted above but not listed here — see OBIO's full Form 4 filing history on SEC EDGAR.

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to OBIO's (Nov 20, 2026).

Frequently asked about OBIO insider activity

How many insiders bought OBIO stock in these Form 4 filings?

7 distinct insiders at Orchestra BioMed Holdings, Inc. reported 12 open-market purchases (Form 4 code P) of OBIO shares between May 18, 2026 and Nov 20, 2026, the most recent filed by Andrew Lawrence Taylor (Chief Financial Officer) on Nov 9, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for OBIO?

The most recent Form 4 on this page was filed by Andrew Lawrence Taylor (Chief Financial Officer) on Nov 20, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market OBIO insider purchase shown?

The largest open-market purchase among the filings shown was 1,200,000 OBIO shares at $5.00 (about $6,000,000) by RTW Investments, LP (10% owner) on Nov 9, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent OBIO insider purchases have the Form 4 10b5-1 box checked?

No. All 12 OBIO open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Andrew Lawrence Taylor (Chief Financial Officer) on Nov 9, 2026, 1,000 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for OBIO — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.